Single-Compound vs. Blended Research Formulas: A Distributor’s Reference

Alongside single-compound vials, research catalogues increasingly list blended formulas: a single lyophilized preparation containing several peptides in a fixed ratio. Products such as multi-component tissue-research blends fall into this category. For distributors deciding what to stock, it helps to understand how blends differ from single compounds and what documentation to expect.

What a blend actually is

A blend is several characterised research peptides combined into one vial at a defined ratio. A three-part formula might pair complementary research peptides; a four-part formula adds a further component. The appeal is convenience — one vial provides a fixed, repeatable multi-component reference rather than requiring a laboratory to combine separate stocks each time.

Documentation differences

A single compound has one molecular weight, one CAS number and one straightforward purity figure. A blend is documented differently:

• There is no single molecular weight or CAS number for the mixture as a whole.
• Purity is best reported per component, since each peptide is verified individually.
• The ratio between components should be stated and consistent batch to batch.

When evaluating a blend, look for a Certificate of Analysis that addresses each constituent rather than a single combined number. A blend that only reports one figure is harder to verify.

Handling and reconstitution

Blends reconstitute much like single compounds — typically in sterile or bacteriostatic water — but the total milligram figure refers to the combined mass of all components. A 70mg or 80mg blend is divided across its constituents according to the stated ratio, so the amount of any individual peptide is a fraction of the total. Keep that in mind when calculating working concentrations.

Inventory considerations for distributors

• Clarity of labelling: the components and total milligram figure should be unambiguous on the listing.
• Batch consistency: the ratio should not drift between lots.
• Per-component testing: documentation should cover each peptide.
• Storage: the same −20°C, sealed, dark, dry rules apply as for single compounds.

Choosing between the two

Single compounds offer maximum flexibility and the simplest documentation. Blends offer convenience and a fixed multi-component reference. Many catalogues carry both, and stocking a small range of well-documented blends alongside the core single-compound list lets a distributor serve laboratories that want either approach.

All single compounds and blends referenced are research-grade reference materials for laboratory use only and are not for human or animal consumption.